Allopurinol and Pathogenesis of Cirrhosis | MicrobiomeTrials← Back to trialsNCT07033533
Allopurinol and Pathogenesis of Cirrhosis
CompletedPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2023-06-01Est. Completion: 2024-03-01
Enrollment target: 100 participants Locations- Tanta University, Tanta, Egypt
Other microbiome trials you might be interested in
Cirrhoses, LiverDecompensated Cirrhosis of Liver
Cirrhosis, a leading cause of global mortality, progresses to life-threatening complications like ascites, hepatic encep…
Dhaka, BangladeshEst. completion Dec 2026
Cirrhoses, Liver
The goal of this clinical trial is to test a low-touch vs high-touch drug-free pain self-management program that may hel…
San Francisco, United StatesEst. completion Mar 1, 2030